The unwinding related section 1902(e)(14) strategies newly available to Medicaid and CHIP agencies can provide significant relief to states facing pending eligibility and enrollment actions and processing delays, workforce and systems limitations, and other operational challenges. Ensuring eligible individuals do not lose coverage for procedural or administrative reasons and supporting those who are ineligible for Medicaid/CHIP transition to Marketplace coverage will be paramount for all states as they begin to resume normal operations when the federal public health emergency (PHE) ends. This expert perspective outlines the time-limited targeted enrollment flexibilities that CMS has availed to states through section 1902(e)(14) waiver authority and discusses considerations beyond the strategies described in federal guidance and supplemental resources.
Medicaid: States’ Most Powerful Tool to Combat the Opioid Crisis
Deborah Bachrach, Patricia Boozang, and Mindy Lipson, Manatt Health
With the United States in the midst of a worsening opioid epidemic, an examination of the resources and tools available to states in combating this crisis is critical. With Medicaid serving as the largest source of coverage for behavioral health services, including those related to substance use disorders (SUDs), the role that it can occupy in addressing the epidemic is clear. An additional 1.2 million individuals with SUDs have gained access to coverage in states that have expanded Medicaid under the ACA. This issue brief, developed by Manatt Health, reviews Medicaid strategies to combat the opioid epidemic. The issue brief underscores the vital nature of Medicaid expansion as part of this effort, with at least 1.1 million adults with SUDs currently residing in non-expansion states. The issue brief is part of a continuing series investigating the fiscal implications of Medicaid expansion.